Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

For Generics Industry, Will Larger Firms Mean Weaker Lobbying?

Executive Summary

New CEO Chip Davis wants GPhA sitting at the table in policy debates rather than being on the menu, but industry consolidation means there are fewer dues-paying members to fill the chairs.


Related Content

GPhRMA? Generic Trade Group Picks Up Another Exec From Brand Association
Pricing Transparency Policies Not Suited To Generics, GPhA Argues
PhRMA Embraces Teva Across Brand-Generic Divide
If You Can't Beat 'Em … Hire 'Em? PhRMA Exec Is New GPhA CEO
Biosimilars Forum: How Do You Create A Brand-Generic Coalition? Don’t Talk About Naming
GPhA And Actavis Divorcing: Biosimilars Behind The Rift


Related Companies